Kora Saúde Participações S.A.
B3:KRSA3.SA
0.5 (BRL) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) BRL.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 2,259.687 | 2,046.729 | 1,261.856 | 875.309 | 442.035 | 284.189 | 263.652 |
| Kosten van de omzet
| 1,831.558 | 1,558.784 | 939.155 | 594.728 | 313.358 | 205.044 | 111.285 |
| Brutowinst
| 428.129 | 487.945 | 322.701 | 280.581 | 128.677 | 79.145 | 152.367 |
| Brutowinstmarge
| 0.189 | 0.238 | 0.256 | 0.321 | 0.291 | 0.278 | 0.578 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 61.962 | 20.359 | 7.413 | 141.601 | 6.035 | 4.558 | 44.838 |
| Verkoop- en marketingkosten
| 85.988 | 0 | 0 | 0 | 0 | 82.574 | 73.304 |
| Verkoop-, algemene en administratieve kosten
| 147.95 | 20.359 | 7.413 | 141.601 | 6.035 | 4.558 | 118.142 |
| Overige kosten
| 0.017 | -0.469 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 147.933 | 220.055 | 190.727 | 134.137 | 83.134 | 57.005 | 120.024 |
| Bedrijfsresultaat
| 280.196 | 202.697 | 109.301 | 152.908 | 45.873 | 23.163 | 32.896 |
| Bedrijfsresultaat ratio
| 0.124 | 0.099 | 0.087 | 0.175 | 0.104 | 0.082 | 0.125 |
| Totaal overige inkomsten en kosten netto
| -418.097 | -292.416 | -106.467 | -114.05 | -37.825 | -14.169 | -16.485 |
| Inkomen voor belasting
| -137.901 | -89.719 | 2.834 | 38.858 | 8.048 | 8.994 | 16.411 |
| Inkomen voor belasting ratio
| -0.061 | -0.044 | 0.002 | 0.044 | 0.018 | 0.032 | 0.062 |
| Belastingkosten
| 24.084 | 4.749 | 57.789 | 16.084 | 10.375 | 6.953 | 8.188 |
| Nettowinst
| -167.624 | -107.588 | -63.718 | 15.871 | -2.842 | 1.776 | 5.973 |
| Nettowinstmarge
| -0.074 | -0.053 | -0.05 | 0.018 | -0.006 | 0.006 | 0.023 |
| WPA (Winst Per Aandeel)
| -0.22 | -0.14 | -0.11 | 0.021 | -0.004 | 0.002 | 0 |
| Verwaterde WPA
| -0.22 | -0.14 | -0.11 | 0.021 | -0.004 | 0.002 | 0 |
| EBITDA
| 447.767 | 326.767 | 182.57 | 180.897 | 62.065 | 29.645 | 39.827 |
| EBITDA ratio
| 0.198 | 0.16 | 0.145 | 0.207 | 0.14 | 0.104 | 0.151 |